BHLHE41 and lip and oral cavity carcinoma: Interestingly, DEC2 have been demonstrated to suppress the progression of breast, endometrial, pancreatic and oral cancers [13, 21, 28, 29]; however, DEC2 was suggested to be an oncogene in osteosarcoma.